Previous Article | Next Article 
Molecular and Cellular Biology, September 2000, p. 6300-6307, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
p12DOC-1 Is a Novel Cyclin-Dependent Kinase
2-Associated Protein
Satoru
Shintani,1
Hiroe
Ohyama,1
Xue
Zhang,1,2
Jim
McBride,1
Kou
Matsuo,1
Takanori
Tsuji,1
Miaofen G.
Hu,1
Guofu
Hu,3
Yohko
Kohno,1
Michael
Lerman,4
Randy
Todd,5 and
David T. W.
Wong1,*
Laboratory of Molecular
Pathology1 and Laboratory of Oral and
Maxillofacial Surgery,5 School of Dental
Medicine, and Center for Biochemical and Biophysical Sciences
and Medicine, Medical School,3 Harvard
University, Boston, Massachusetts 02115; Department of Cell
Biology, China Medical University, Shenyang, People's Republic of
China2; and Intramural Research Support
Program, SAIC Frederick, and Laboratory of Immunobiology, DBS,
National Cancer Institute-Frederick Cancer Research and Development
Center, Frederick, Maryland 217024
Received 15 December 1999/Returned for modification 8 February
2000/Accepted 15 June 2000
Regulated cyclin-dependent kinase (CDK) levels and activities are
critical for the proper progression of the cell division cycle.
p12DOC-1 is a growth suppressor isolated from normal
keratinocytes. We report that p12DOC-1 associates with
CDK2. More specifically, p12DOC-1 associates with the
monomeric nonphosphorylated form of CDK2 (p33CDK2). Ectopic expression
of p12DOC-1 resulted in decreased cellular CDK2 and
reduced CDK2-associated kinase activities and was accompanied by
a shift in the cell cycle positions of p12DOC-1
transfectants (
G1 and
S).
The p12DOC-1-mediated decrease of CDK2 was prevented if the
p12DOC-1 transfectants were grown in the presence
of the proteosome inhibitor clasto-lactacystin
-lactone,
suggesting that p12DOC-1 may target CDK2 for proteolysis. A
CDK2 binding mutant was created and was found to revert
p12DOC-1-mediated, CDK2-associated cell cycle phenotypes.
These data support p12DOC-1 as a specific CDK2-associated
protein that negatively regulates CDK2 activities by sequestering the
monomeric pool of CDK2 and/or targets CDK2 for proteolysis, reducing
the active pool of CDK2.
*
Corresponding author. Mailing address: Harvard
University, School of Dental Medicine, 188 Longwood Ave., Boston, MA
02115. Phone: (617) 432-1834. Fax: (617) 432-2449. E-mail:
David_Wong{at}hms.med.harvard.edu.
Molecular and Cellular Biology, September 2000, p. 6300-6307, Vol. 20, No. 17
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kim, Y., Deshpande, A., Dai, Y., Kim, J. J., Lindgren, A., Conway, A., Clark, A. T., Wong, D. T.
(2009). Cyclin-dependent Kinase 2-associating Protein 1 Commits Murine Embryonic Stem Cell Differentiation through Retinoblastoma Protein Regulation. J. Biol. Chem.
284: 23405-23414
[Abstract]
[Full Text]
-
Deshpande, A. M., Dai, Y.-S., Kim, Y., Kim, J., Kimlin, L., Gao, K., Wong, D. T.
(2009). Cdk2ap1 Is Required for Epigenetic Silencing of Oct4 during Murine Embryonic Stem Cell Differentiation. J. Biol. Chem.
284: 6043-6047
[Abstract]
[Full Text]
-
Tsuji, T., Ibaragi, S., Shima, K., Hu, M. G., Katsurano, M., Sasaki, A., Hu, G.-f.
(2008). Epithelial-Mesenchymal Transition Induced by Growth Suppressor p12CDK2-AP1 Promotes Tumor Cell Local Invasion but Suppresses Distant Colony Growth. Cancer Res.
68: 10377-10386
[Abstract]
[Full Text]
-
Miguel, M. C. d. C., Oliveira, M. C., Seabra, F. R. G., Queiroz, L. M. G., Freitas, R. d. A., Batista de Souza, L.
(2005). {beta}-Catenin and Cyclin D1 in Mucoepidermoid Carcinoma of Variable Histologic Grades. Arch Otolaryngol Head Neck Surg
131: 701-706
[Abstract]
[Full Text]
-
Kim, Y., Ohyama, H., Patel, V., Figueiredo, M., Wong, D. T.
(2005). Mutation of Cys105 Inhibits Dimerization of p12CDK2-AP1 and Its Growth Suppressor Effect. J. Biol. Chem.
280: 23273-23279
[Abstract]
[Full Text]
-
Figueiredo, M. L., Kim, Y., St. John, M. A.R., Wong, D. T.W.
(2005). p12CDK2-AP1 Gene Therapy Strategy Inhibits Tumor Growth in an In vivo Mouse Model of Head and Neck Cancer. Clin. Cancer Res.
11: 3939-3948
[Abstract]
[Full Text]
-
Hu, M. G., Hu, G.-F., Kim, Y., Tsuji, T., McBride, J., Hinds, P., Wong, D. T. W.
(2004). Role of p12CDK2-AP1 in Transforming Growth Factor-{beta}1-Mediated Growth Suppression. Cancer Res.
64: 490-499
[Abstract]
[Full Text]
-
Terret, M. E., Lefebvre, C., Djiane, A., Rassinier, P., Moreau, J., Maro, B., Verlhac, M.-H.
(2003). DOC1R: a MAP kinase substrate that control microtubule organization of metaphase II mouse oocytes. Development
130: 5169-5177
[Abstract]
[Full Text]
-
Shibutani, M., Takahashi, N., Kobayashi, T., Uneyama, C., Masutomi, N., Nishikawa, A., Hirose, M.
(2002). Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay. Carcinogenesis
23: 1047-1055
[Abstract]
[Full Text]
-
Shintani, S., Mihara, M., Terakado, N., Nakahara, Y., Matsumura, T., Kohno, Y., Ohyama, H., McBride, J., Kent, R., Todd, R., Tsuji, T., Wong, D. T. W.
(2001). Reduction of p12DOC-1 Expression Is a Negative Prognostic Indicator in Patients with Surgically Resected Oral Squamous Cell Carcinoma. Clin. Cancer Res.
7: 2776-2782
[Abstract]
[Full Text]